Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology

被引：485

作者：

Hallberg, Bengt ^{[1
]}

Palmer, Ruth H. ^{[1
]}

机构：

[1] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden

来源：

NATURE REVIEWS CANCER | 2013年 / 13卷 / 10期

基金：

瑞典研究理事会;

关键词：

ANAPLASTIC LYMPHOMA KINASE; LARGE-CELL LYMPHOMA; INFLAMMATORY MYOFIBROBLASTIC TUMOR; NPM-ALK; LUNG-CANCER; MOLECULAR CHARACTERIZATION; DOWN-REGULATION; TRUNCATED FORM; GROWTH-FACTOR; FUSION GENE;

D O I：

10.1038/nrc3580

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The burgeoning field of anaplastic lymphoma kinase (ALK) in cancer encompasses many cancer types, from very rare cancers to the more prevalent non-small-cell lung cancer (NSCLC). The common activation of ALK has led to the use of the ALK tyrosine kinase inhibitor (TKI) crizotinib in a range of patient populations and to the rapid development of second-generation drugs targeting ALK. In this Review, we discuss our current understanding of ALK function in human cancer and the implications for tumour treatment.

引用

页码：685 / 700

页数：16

共 50 条

[11] NADPH Oxidase Biology and the Regulation of Tyrosine Kinase Receptor Signaling and Cancer Drug Cytotoxicity
Paletta-Silva, Rafael
Rocco-Machado, Nathalia
Meyer-Fernandes, Jose Roberto
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (02): : 3683 - 3704
[12] Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system
Toshinori Iwahara
Jiro Fujimoto
Duanzhi Wen
Rod Cupples
Nathan Bucay
Tsutomu Arakawa
Shigeo Mori
Barry Ratzkin
Tadashi Yamamoto
Oncogene, 1997, 14 : 439 - 449
[13] The Receptor Tyrosine Kinase Alk Controls Neurofibromin Functions in Drosophila Growth and Learning
Gouzi, Jean Y.
Moressis, Anastasios
Walker, James A.
Apostolopoulou, Anthi A.
Palmer, Ruth H.
Bernards, Andre
Skoulakis, Efthimios M. C.
PLOS GENETICS, 2011, 7 (09):
[14] ROS1 as a 'druggable' receptor tyrosine kinase: lessons learned from inhibiting the ALK pathway
Ou, Sai-Hong Ignatius
Tan, Jackie
Yen, Yun
Soo, Ross A.
EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (04) : 447 - 456
[15] Oncogenic tyrosine kinase NPM-ALK induces expression of the growth-promoting receptor ICOS
Zhang, Qian
Wang, HongYi
Kantekure, Kanchan
Paterson, Jennifer C.
Liu, Xiaobin
Schaffer, Andras
Paulos, Chrystal
Milone, Michael C.
Odum, Niels
Turner, Suzanne
Marafioti, Teresa
Wasik, Mariusz A.
BLOOD, 2011, 118 (11) : 3062 - 3071
[16] Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system
Iwahara, T
Fujimoto, J
Wen, DZ
Cupples, R
Bucay, N
Arakawa, T
Mori, S
Ratzkin, B
Yamamoto, T
ONCOGENE, 1997, 14 (04) : 439 - 449
[17] Mechanisms of receptor tyrosine kinase activation in cancer
Du, Zhenfang
Lovly, Christine M.
MOLECULAR CANCER, 2018, 17
[18] The Drosophila Receptor Tyrosine Kinase Alk Constrains Long-Term Memory Formation
Gouzi, Jean Y.
Bouraimi, Mikela
Roussou, Ilianna G.
Moressis, Anastasios
Skoulakis, Efthimios M. C.
JOURNAL OF NEUROSCIENCE, 2018, 38 (35) : 7701 - 7712
[19] High ALK Receptor Tyrosine Kinase Expression Supersedes ALK Mutation as a Determining Factor of an Unfavorable Phenotype in Primary Neuroblastoma
Schulte, Johannes H.
Bachmann, Hagen S.
Brockmeyer, Bent
DePreter, Katleen
Oberthuer, Andre
Ackermann, Sandra
Kahlert, Yvonne
Pajtler, Kristian
Theissen, Jessica
Westermann, Frank
Vandesompele, Jo
Speleman, Frank
Berthold, Frank
Eggert, Angelika
Brors, Benedikt
Hero, Barbara
Schramm, Alexander
Fischer, Matthias
CLINICAL CANCER RESEARCH, 2011, 17 (15) : 5082 - 5092
[20] Anaplastic lymphoma kinase in human cancer
Barreca, Antonella
Lasorsa, Elena
Riera, Ludovica
Machiorlatti, Rodolfo
Piva, Roberto
Ponzoni, Maurilio
Kwee, Ivo
Bertoni, Francesco
Piccaluga, Pier Paolo
Pileri, Stefano A.
Inghirami, Giorgio
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2011, 47 (01) : R11 - R23

← 1 2 3 4 5 →